Clinical Trials Logo

Clinical Trial Details — Status: Completed

Administrative data

NCT number NCT02119325
Other study ID # 202180
Secondary ID RH01899
Status Completed
Phase N/A
First received April 17, 2014
Last updated May 11, 2015
Start date September 2013

Study information

Verified date April 2015
Source GlaxoSmithKline
Contact n/a
Is FDA regulated No
Health authority India: Independent Ethics Committee
Study type Interventional

Clinical Trial Summary

The primary aim of this study is to evaluate the effect of a fibre rich health food drink on the post prandial glucose and triglyceride peak in healthy overweight adults with impaired fasting glucose (IFG). The study is randomised, stratified, double blind, two treatments, two period cross over study.


Recruitment information / eligibility

Status Completed
Enrollment 96
Est. completion date
Est. primary completion date October 2013
Accepts healthy volunteers Accepts Healthy Volunteers
Gender Both
Age group 18 Years to 75 Years
Eligibility Inclusion Criteria:

- Healthy overweight male and female participants

- Age 18-75 years

- BMI =25<35 Kg/m2

Exclusion Criteria:

- Pregnancy/breast-feeding

- Allergy/Intolerance

- Anaemic participants: Hb <10g/dL

- Diabetic participants: fasting blood glucose >125 mg/dL

- Serum Aspartate Transaminase, Alkaline Phosphatase and Serum albumin level 3 times the upper limit of normal range

- Participants on other medications (lipid lowering drugs, oral hypoglycemics)

Study Design

Allocation: Randomized, Endpoint Classification: Safety/Efficacy Study, Intervention Model: Crossover Assignment, Masking: Double Blind (Subject, Investigator)


Related Conditions & MeSH terms


Intervention

Dietary Supplement:
25% fibre
Test is a powdered beverage with an active component of 25% of fibre (resistant maltodextrin)
0% fibre
Placebo is an energy matched powdered beverage

Locations

Country Name City State
India Lambda Therapeutic Research Ltd Ahmedabad Gujarat

Sponsors (1)

Lead Sponsor Collaborator
GlaxoSmithKline

Country where clinical trial is conducted

India, 

Outcome

Type Measure Description Time frame Safety issue
Primary Cmax for Glucose in IFG Status Participants To evaluate the effect of fibre rich health food drink on post prandial peak (Cmax) for glucose in healthy overweight adults with impaired fasting glucose (IFG) Blood samples will be taken at -35, 10, 20, 30, 40, 50, 60, 75, 90, 105, 120, 150, 180, 210 & 240 minutes No
Primary Cmax for Triglyceride in IFG Status Participants To evaluate the effect of fibre rich health food drink on post prandial peak (Cmax) for triglyceride in healthy overweight adults with IFG Blood samples will be taken at -35, 10, 20, 30, 40, 50, 60, 75, 90, 105, 120, 150, 180, 210 & 240 minutes No
Secondary Cmax for Glucose in Overweight Healthy Participants To evaluate the effect of fibre rich health food drink on post prandial peak (Cmax) for glucose in healthy overweight adults Blood samples will be taken at -35, 10, 20, 30, 40, 50, 60, 75, 90, 105, 120, 150, 180, 210 & 240 minutes No
Secondary AUC for Glucose in Overweight Healthy Participants To evaluate the effect of fibre rich health food drink on area under the curve (AUC) for glucose in healthy overweight adults Blood samples will be taken at -35, 10, 20, 30, 40, 50, 60, 75, 90, 105, 120, 150, 180, 210 & 240 minutes No
Secondary Tmax for Glucose in Overweight Healthy Participants To evaluate the effect of fibre rich health food drink on the time when maximum post prandial concentration is reached (Tmax) of blood glucose in healthy overweight adults Blood samples will be taken at -35, 10, 20, 30, 40, 50, 60, 75, 90, 105, 120, 150, 180, 210 & 240 minutes No
Secondary Cmax for Triglyceride in Overweight Healthy Participants To evaluate the effect of fibre rich health food drink on post prandial peak (Cmax) for triglyceride in healthy overweight adults Blood samples will be taken at -35, 10, 20, 30, 40, 50, 60, 75, 90, 105, 120, 150, 180, 210 & 240 minutes No
Secondary AUC for Triglycerides in Overweight Healthy Participants To evaluate the effect of fibre rich health food drink on area under the curve (AUC) for triglycerides in healthy overweight adults Blood samples will be taken at -35, 10, 20, 30, 40, 50, 60, 75, 90, 105, 120, 150, 180, 210 & 240 minutes No
Secondary Tmax for Triglycerides in Overweight Healthy Participants To evaluate the effect of fibre rich health food drink on Tmax of triglycerides in healthy overweight adults Blood samples will be taken at -35, 10, 20, 30, 40, 50, 60, 75, 90, 105, 120, 150, 180, 210 & 240 minutes No
Secondary Cmax for RLP Cholesterol in IFG Status Participants To evaluate the effect of fibre rich health food drink on post prandial Remnant Lipoprotein Cholesterol (RLP Cholesterol) peak (Cmax) in healthy overweight adults with IFG Blood samples will be taken at -35, 10, 20, 30, 40, 50, 60, 75, 90, 105, 120, 150, 180, 210 & 240 minutes No
Secondary AUC for RLP Cholesterol in IFG Status Participants To evaluate the effect of fibre rich health food drink on AUC for RLP Cholesterol in healthy overweight adults with IFG Blood samples will be taken at -35, 10, 20, 30, 40, 50, 60, 75, 90, 105, 120, 150, 180, 210 & 240 minutes No
Secondary Tmax for RLP Cholesterol in IFG Status Participants To evaluate the effect of fibre rich health food drink on Tmax for RLP Cholesterol in healthy overweight adults with IFG Blood samples will be taken at -35, 10, 20, 30, 40, 50, 60, 75, 90, 105, 120, 150, 180, 210 & 240 minutes No
Secondary Cmax for RLP Cholesterol in Overweight Healthy Participants To evaluate the effect of fibre rich health food drink on post prandial RLP Cholesterol peak (Cmax) in healthy overweight adults Blood samples will be taken at -35, 10, 20, 30, 40, 50, 60, 75, 90, 105, 120, 150, 180, 210 & 240 minutes No
Secondary AUC for RLP Cholesterol in Overweight Healthy Participants To evaluate the effect of fibre rich health food drink on AUC for RLP Cholesterol in healthy overweight adults Blood samples will be taken at -35, 10, 20, 30, 40, 50, 60, 75, 90, 105, 120, 150, 180, 210 & 240 minutes No
Secondary Tmax for RLP Cholesterol in Overweight Healthy Participants To evaluate the effect of fibre rich health food drink on Tmax of RLP Cholesterol in healthy overweight adults Blood samples will be taken at -35, 10, 20, 30, 40, 50, 60, 75, 90, 105, 120, 150, 180, 210 & 240 minutes No
Secondary Cmax for Insulin in IFG Status Participants To evaluate the effect of fibre rich health food drink on post prandial peak (Cmax) for insulin in healthy overweight adults with IFG Blood samples will be taken at -35, 10, 20, 30, 40, 50, 60, 75, 90, 105, 120, 150, 180, 210 & 240 minutes No
Secondary AUC for Insulin in IFG Status Participants To evaluate the effect of fibre rich health food drink on AUC for insulin in healthy overweight adults with IFG Blood samples will be taken at -35, 10, 20, 30, 40, 50, 60, 75, 90, 105, 120, 150, 180, 210 & 240 minutes No
Secondary Tmax for Insulin in IFG Status Participants To evaluate the effect of fibre rich health food drink on Tmax for insulin in healthy overweight adults with IFG Blood samples will be taken at -35, 10, 20, 30, 40, 50, 60, 75, 90, 105, 120, 150, 180, 210 & 240 minutes No
Secondary Cmax for Insulin in Overweight Healthy Participants To evaluate the effect of fibre rich health food drink on post prandial peak (Cmax) for insulin in healthy overweight adults Blood samples will be taken at -35, 10, 20, 30, 40, 50, 60, 75, 90, 105, 120, 150, 180, 210 & 240 minutes No
Secondary AUC for Insulin in Overweight Healthy Participants To evaluate the effect of fibre rich health food drink on AUC for insulin in healthy overweight adults Blood samples will be taken at -35, 10, 20, 30, 40, 50, 60, 75, 90, 105, 120, 150, 180, 210 & 240 minutes No
Secondary Tmax for Insulin in Overweight Healthy Participants To evaluate the effect of fibre rich health food drink on Tmax for insulin in healthy overweight adults Blood samples will be taken at -35, 10, 20, 30, 40, 50, 60, 75, 90, 105, 120, 150, 180, 210 & 240 minutes No
See also
  Status Clinical Trial Phase
Completed NCT01488279 - Effect of Sitagliptin on Short-Term Metabolic Dysregulation of Oral Glucocorticoid Therapy N/A
Completed NCT00990184 - Study to Evaluate the Effects of Colesevelam on Insulin Sensitivity and ß-Cell Function in Subjects With Impaired Fasting Glucose (Prediabetes) Phase 3
Completed NCT00573781 - Dietary Modulation of Gene Expression and Metabolic Pathways in Glucose Metabolism Phase 2
Terminated NCT01204216 - Effect of Red Blood Cell Survival on a Commonly Used Diabetes Lab Test-HbA1c N/A
Completed NCT02700334 - Effect of Dapagliflozin on Insulin Secretion and Insulin Sensitivity in Patients With Prediabetes Phase 4
Active, not recruiting NCT01933529 - ARA290 in T2D (Effects of ARA 290, an Erythropoietin Analogue) in Prediabetes and Type 2 Diabetes) Phase 2
Completed NCT01729078 - Dietary Interventions in Prediabetes N/A
Completed NCT02896010 - Personalized Smartphone-assisted Coaching System to Improve Glucose Homeostasis in Adults With Prediabetes N/A
Completed NCT03650023 - A Crossover Trial of Chitosan Oligosaccharide on Post Prandial Glucose Control in Subjects With Normal, IFG and IGT N/A
Completed NCT02542033 - Glycemic Response to Low Sugar Apple Juice N/A
Completed NCT01375660 - D Vitamin Intervention in VA N/A
Active, not recruiting NCT03029390 - Effect of Berberine Versus Metformin on Glycemic Control, Insulin Sensitivity and Insulin Secretion in Prediabetes Phase 4
Completed NCT00259168 - Insulin Resistance and Vessel Function After Meals: Does Early Intervention Make a Difference? Phase 4
Completed NCT01807351 - Progression From Impaired Fasting Glucose to Type 2 Diabetes Mellitus Among Subjects With and Without Hypertension in Primary Care Setting N/A
Completed NCT01386645 - Effect of Dietary Glycemic Index on Beta-cell Function N/A
Completed NCT05544825 - Ice Plant (Mesembryanthemum Crystallinum) Extract in Patients With Impaired Fasting Glucose N/A
Withdrawn NCT03315663 - Personalized Smartphone-assisted Coaching System to Improve Glucose Homeostasis in Adults With Prediabetes - Main Study N/A
Completed NCT01895387 - Dietary Effects on Circulating Lipoprotein-associated Phospholipase A2 (Lp-PLA2) Activity and Enzyme Activity in Peripheral Blood Mononuclear Cells (PBMCs) in Patients With Prediabetes or Newly Diagnosed Type 2 Diabetes N/A
Completed NCT03419702 - Almonds and Health Effects on Metabolism, Vascular Function and Cognition N/A
Completed NCT01549600 - Comparison of Psyllium and Microcrystalline Cellulose on Glycemic Measures in Subjects With Impaired Fasting Glucose N/A